Navigation Links
Research talent wins national Innovation in Nursing award
Date:5/16/2008

ion.

Professor Rickard was selected from a strong field of six national finalists whose innovations included a rock CD promoting sexual health, the use of professional actors to train nurses to cope with patient grief and anxiety and the introduction of massage therapy for surgery patients.

HESTA CEO Anne-Marie Corboy said the industry super fund was proud to support such an outstanding awards program.

She congratulated the winners in the three categories: Nurse of the Year (WAs Samantha Gibson), Innovation in Nursing (Queenslands Claire Rickard) and Graduate Nurse of the Year (Victorian Kelly Leiper).

Every Australian has been touched, in some way, by the dedication and professionalism of nurses, Ms Corboy said.

The HESTA Australian Nursing Awards are a chance to acknowledge three stars of the profession, and to say thank you to all those women and men in nursing whose care transforms our lives.


'/>"/>

Contact: Claire Rickard
61-413-398-482
Research Australia
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. New Mount Sinai research tracks effects of addictive drugs on brain
2. Medical College of Wisconsin researchers identify proteins that help develop mammalian hearts
3. Mastectomies on the rise and MRI use may explain part of the trend, say Mayo researchers
4. Anesiva Announces May 22, 2008 Presentation at Citi Investment Research Global HealthCare Conference
5. UCSD researchers show link between vitamin D status, breast cancer
6. Theranostics Health Signs Research Collaboration Agreement
7. The 2008 AMIA Spring Congress to Showcase Best Practices and Innovations in Biomedical and Health Informatics Research and Education
8. Kids Growing Up on Grown Up Drugs: New Research Shows Treatments for Adult Ailments Rapidly Rising in Children
9. Insulet Corporation to Present at the Seventh Annual JMP Securities Research Conference on May 20, 2008
10. Cynosure to Present at 2008 Citi Investment Research Global Health Care Conference
11. Alexzas Corporate Presentation to be Webcast at the Seventh Annual JMP Securities Research Conference and the 2008 Citi Investment Research Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...s weight pattern in France reveals that French peo...ter//. According to the ObEpi-Roche survey, almos... is affected by weight problem, with 1/3rd of it b...Obesity is on a high in France, in spite of the pe...
...th survey has revealed that Maori are almost twice...h more likely to suffer// from mental disorder gen...cted by the Health Ministry has been the first to ...ce of mental disorders among different ethnic grou...
...ding registered nurses and doctors from Doctors Me...on the Contra Costa County Board of Supervisors// ... a unanimous vote from the hospital’s board of dir...nt to file for bankruptcy. Nurse Tami Roncskevitz ...
...s suggest a short-term application of topical cort...nt for patients// with intertriginous psoriasis (I...r issue of Archives of Dermatology, one of the JAM...inflammatory skin disease. In a subset of patient...
Other Medicine News:Health News:Obesity on a high in France 2Health News:Bankruptcy forces Hospital staff to Call For County Takeover 2Health News:Bankruptcy forces Hospital staff to Call For County Takeover 3Health News:Short-Term Topical Corticosteroid May Offer Relief for Certain Type of Psoriasis 2
(Date:10/13/2008)...nd SPIRIT III Data Confirms Patients Treated, with... a Heart Attack or a Repeat Procedure Co... 13 /- Data from an indepen...T III randomized clinical,trials demonstrated that...t,System continues to deliver clinically significa...
(Date:10/13/2008)...nd to Have Higher Sensitivity and Specificity, th...d was the preferred test in all ph...t. 13 /- AT First Diagnostic LLC an,e...stic test kits, today,announced that a recent eval... of Research of the FirstVue(TM) HBSAG Test, was r...
(Date:10/13/2008)... /- Facet Solutions, Inc. today,annou...ients from its US,IDE Pilot Study. The results sho...I) scores, and an 80% reduction in Visual Analog S... President & CEO for Facet Solutions,added, "We a...us far not,only demonstrate significant pain relie...
(Date:10/12/2008)...TON, Oct. 12 /- Boston,Scie...esults from an analysis,of nearly 7,500 patients f... designed to confirm the performance of the TAXUS(...System in real-world practice. The,two-year pooled...linical,restenosis in patients with diabetes as ef...
Breaking Medicine Technology:Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 2Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 3Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 4Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years 5Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 2Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 3Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Cancer Drug Appears to Help With Aggressive MS 21744 1Cancer Drug Appears to Help With Aggressive MS 21744 2MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery 21741 1MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery 21741 2MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery 21741 3Chindex International Inc Quantifies Fourth Quarter Charges 5970 1Chindex International Inc Quantifies Fourth Quarter Charges 5970 2Chindex International Inc Quantifies Fourth Quarter Charges 5970 3AAAS hosts June 20 conference on personalized medicine 21736 1AAAS hosts June 20 conference on personalized medicine 21736 2
...S WIRE)--Jul 9, 2007 - Neose Technologies,Inc. (N... at the,C.E. Unterberg, Towbin Emerging Growth Opp...l Hotel in New York City from July,10-12, 2007. Th....,(EDT) on Tuesday, July 10, 2007. The presentatio...a the following link:, http://www.wsw.com/webcast/...
...y 05, 2007 /PRNewswire/ -- Alfacell,Corporation to...ice,president, chief financial officer and corpora...any,s product development programs,at 8 a.m. EDT o...Towbin Emerging Growth Opportunities Conference in... be available live at,<a target="_blank" href=,"ht...
Other Medicine Technology:Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging,Growth Opportunities Conference 2
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
Sugar-Chex Linearity is a whole blood formulation designed to cover the linear reportable range of the most popular glucose meters. The product meets CAP recommendations of using a control matrix tha
Medicine Products: